ACET

Adicet Bio, Inc. - Common Stock (ACET)

About Adicet Bio, Inc. - Common Stock (ACET)

Adicet Bio, Inc. is a clinical stage biotechnology company, which engages in discovering and developing allogeneic gamma delta T cell therapies for cancer. It also focuses on developing a pipeline of “off-the-shelf” gamma delta T cells. The company was founded by Aya Jakobovits in November 2014 and is headquartered in Boston, MA.

Details

Daily high

$0.73

Daily low

$0.68

Price at open

$0.71

52 Week High

$1.70

52 Week Low

$0.45

Market cap

57.9M

Dividend yield

0.00%

Volume

399,521

Avg. volume

674,030

P/E ratio

-.54

Adicet Bio, Inc. - Common Stock News